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The adjuvant properties of the saponin QS-21 have been known for decades. It is a 
component of the Adjuvant System AS01 that is used in several vaccine candidates. 
QS-21 strongly potentiates both cellular and humoral immune responses to purified anti-
gens, yet how it activates immune cells is largely unknown. Here, we report that QS-21 
directly activated human monocyte-derived dendritic cells (moDCs) and promoted a 
pro-inflammatory transcriptional program. Cholesterol-dependent QS-21 endocytosis 
followed by lysosomal destabilization and Syk kinase activation were prerequisites for 
this response. Cathepsin B, a lysosomal cysteine protease, was essential for moDC 
activation in vitro and contributed to the adjuvant effects of QS-21 in vivo. Collectively, 
these findings provide new insights into the pathways involved in the direct activation of 
antigen-presenting cells by a clinically relevant QS-21 formulation.
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inTrODUcTiOn
Purified recombinant antigens generally elicit weak immune responses in vaccines unless they are co-
formulated with adjuvants. Adjuvants stimulate the innate immune response, which in turn shapes 
cell-mediated and humoral responses that eventually confer protection against pathogens. Saponins 
are a class of molecules that possess adjuvant activity. QuilA, a mixture of saponins extracted from 
the bark of the Quillaja saponaria tree, is a potent adjuvant that stimulates cell-mediated and humoral 
responses (1). A water-soluble triterpene glycoside purified from this mixture, QS-21, possesses 
strong adjuvant activity and limited toxicity when compared to the other fractions (2). In animal 
models, QS-21 is a potent inducer of humoral, Th1 CD4 and cytotoxic CD8 T cell responses (3–5). 
CD8 T cell induction is most likely due to antigen cross-presentation, as has been shown for other 
saponins (6, 7). QS-21 possesses hemolytic activity and thereby intrinsic toxicity, due to saponin 
interaction with membrane cholesterol that leads to pore formation (2, 8). Abrogation of the lytic 
activity of QS-21 is achieved by co-formulation with cholesterol (9), a process used in the Adjuvant 
System AS01 (GSK) that results in reduced toxicity and adverse reactions (10).
Activation of innate cells by adjuvants can shape the subsequent adaptive responses. For example, 
alum stimulates innate cells to produce cytokines such as IL-4 and IL-6 that could explain the polari-
zation toward Th2 responses in mice (11). On the other hand, toll-like receptor (TLR) ligands, such 
as CpG oligodeoxynucleotides, induce the production of IL-12 by innate cells thereby favoring Th1 
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responses (12). The activation of different pattern recognition 
receptors can lead to the production of various cytokines and thus 
alter the adaptive response. It is therefore crucial to understand 
the early pathways activated by adjuvants as this step can have pro-
found effects on the quality of the adaptive response. The mecha-
nisms by which saponins activate antigen-presenting cells are still 
poorly understood. Both QuilA and QS-21 activate the NLRP3 
inflammasome in vitro (13, 14). Furthermore, ISCOMATRIX, an 
adjuvant containing different QuilA fractions also activates the 
inflammasome in vitro and in vivo (15). However, the antigen-
specific responses elicited by QS-21-containing vaccines were 
found to be largely independent of the NLRP3 inflammasome 
pathway, suggesting that other mechanisms must be involved in 
its adjuvanticity (14, 15).
Here, we show that QS-21 directly activated human monocyte-
derived dendritic cells (moDC) and identified specific signaling 
pathways that lead to acute transcriptional activation. We found 
that QS-21 was endocytosed in a cholesterol-dependent manner 
and accumulated in lysosomes. We further demonstrate that 
lysosomal destabilization and cathepsin B activity were central 
for the response of moDCs to QS-21. We also show that absence 
of cathepsin B decreased antigen-specific CD4 and CD8 T cell 
responses in a murine vaccination model.
MaTerials anD MeThODs
cells and reagents
THP-1 (ATCC: Tib202) cells were cultured in medium (RPMI 
containing 10% FCS, l-glutamine, pyruvate, non-essential amino 
acids, 2-mercaptoethanol, and penicillin/streptomycin/gentamy-
cin) and differentiated into macrophages by 200  nM phorbol 
myristate acetate (PMA) for 3 days, then further cultured without 
PMA for 4–5 days. QS-21 (Quillaja saponaria Molina, fraction 
21; licensed by GSK from Antigenics LLC, a wholly owned 
subsidiary of Agenus Inc., a Delaware corporation) and hepatitis 
B surface antigen (HBsAg) were provided by GSK Vaccines. For 
the experiments, QS-21, BODIPY QS-21, and 14C-QS-21 were 
formulated in DOPC liposomes containing cholesterol at 100 µg/
ml. The term “QS-21” used in the manuscript refers to QS-21 
formulated in liposomes. The following reagents were used at the 
indicated concentrations or following manufacturer’s indications: 
Z-VAD-FMK (10  µg/ml—Invivogen), methyl-β-cyclodextrin 
(1/2.5/5/10 μM—Sigma-Aldrich), Bay 61 3606 (10 µM—Sigma-
Aldrich), Bafilomycin A1 (BafA1) (250  nM—Santa Cruz 
Biotechnology), acridine orange (AO) (1 µg/ml—Sigma-Aldrich), 
CA-074 Me (10  µM—PeptaNova), Z-FF-FMK (20  µM—Santa 
Cruz Biotechnology), Z-FA-FMK (20  µM—Santa Cruz 
Biotechnology), pepstatin A (10 µM—Santa Cruz Biotechnology), 
and zymosan (50 µg/ml—Invivogen). For confocal studies, QS-21 
was chemically linked to the green fluorescent dye BODIPY 
(4,4-difluoro-4-bora-3a,4a-diaza-s-indacene). To label QS-21, 
an ester derivative of QS-21 (utilizing the glucuronic acid group) 
was prepared by treating QS-21 (in dimethylformamide) with 
sulfo-N-hydroxysuccinimide and dicyclohexylcarbodiimide, as 
described previously (16). The QS-21-sulfo-NHS ester derivative 
was purified by precipitation with ethyl acetate, then dried and 
suspended in 0.1 M NaHPO4 buffer (pH7), and reacted with an 
excess of BODIPY FL-EDA (which bears an amine group; D2390, 
Life Technologies). The reaction product, BODIPY-QS-21, was 
purified by semi-preparative HPLC and isolated as a powder. 
For endocytosis assays, the 14C-QS-21 was synthesized by GE 
Healthcare. The activity of these analogs was confirmed by a 
hemolysis assay.
moDc generation
Buffy coats from healthy donors who consented to their use for 
scientific research were obtained from local blood donations. 
The study received approval from the Hôpital Erasme Ethics 
Committee (Route de Lennik 808, B-1070 Brussels). Peripheral 
blood mononuclear cells (PBMCs) were purified by density gradi-
ent centrifugation (Lymphoprep—Stemcell Technologies). CD14+ 
monocytes were purified from PBMCs by positive magnetic sepa-
ration with anti-CD14 microbeads (Automacs—Miltenyi Biotec) 
and cultured in 75-cm2 flasks with 20 ml of medium (RPMI con-
taining 10% FCS, penicillin/streptomycin, non-essential amino 
acids, and glutamine) supplemented with recombinant human 
GM-CSF (800 U/ml—Gentaur) and IL-4 (200 U/ml—Wittycell). 
After 3 days, 16,000 U GM-CSF and 4,000 U IL-4 were added to 
the medium. At day 6–7, non-adherent cells corresponding to 
DCs (>90% CD14-negative HLA-DR-positive CD11c-positive) 
were recovered, washed, and used for subsequent experiments.
Mice
Six-week-old C57BL/6 mice were purchased from Harlan Horst. 
Cathepsin B-deficient mice (Ctsb−/−) were previously described 
(17). These mice were housed and bred under specific pathogen-
free conditions. Animal studies were approved by the institutional 
animal care and local committee for animal welfare.
Mice immunization
Six-week-old female mice received injections containing 4  µg 
of HbsAg, 1 µg of ovalbumin (OVA) and 1 µg of QS-21 in the 
gastrocnemius muscles of both hind limbs in a volume of 20 µl 
per muscle. OVA was obtained from Calbiochem and confirmed 
to be endotoxin-free.
endocytosis assay
PMA-differentiated THP-1 cells were incubated at 37°C for 1 or 
4 h with 1 or 10 µg/ml 14C-QS-21, as appropriate, surface-stripped 
by limited trypsin digestion, pelleted, washed, and lysed. 14C 
radioactivity (Tri-Carb 2800TR, Perkin Elmer) was considered 
as intracellular QS-21 and normalized to cell protein. ATP was 
depleted by preincubation with 10 mM azide and 50 mM deoxy-
glucose in RPMI medium without FCS for 20 min. Cholesterol was 
depleted by preincubation with 2.5 mM methyl-β-cyclodextrin 
for 4  h, and then, cells were extensively washed prior tracer 
uptake. This resulted into marginal (5–10%) cell cholesterol loss. 
Endocytosis of 125I-transferrin or -cholera toxin B subunit was 
performed for 15 min, then cells were stripped with trypsin and 
125I counts in lysates were measured with a gamma counter, as 
described in Ref. (18) (except that pronase was replaced by 1% 
trypsin). Uptake was saturable with 14C-QS-21 concentration 
around 10 µg/ml. Accumulation was linear with time for at least 
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6 h indicating lack of degradation and effective retention, which 
was further confirmed by the negligible loss after a 2-h chase. 
14C-QS-21 integrity was confirmed by TLC/phosphorimager.
subcellular Fractionation
After 14C-QS-21 accumulation for 4 h and chase overnight, cells 
were surface stripped with trypsin or not, homogenized, and 
submitted to differential sedimentation to yield postnuclear 
particles as described in Ref. (19). These were mixed with 15% 
Percoll to form a self-generating gradient. Ten fractions of 1 ml 
were collected from the bottom and analyzed for radioactivity 
(stripped: recovery, 80% of homogenate; non-stripped, 50%), 
beta-hexosaminidase activity (stripped or not; >80%), and 
Western blotting for Na+/K+-ATPase (non-stripped cells).
Microscopy
For BODIPY-QS-21 imaging, 105 moDCs were seeded in each 
compartment of compartmented 35-mm sterile culture dishes 
with glass bottom (Cellview—Greiner). Cells were incubated for 
1 h with 10 µg/ml BODIPY-QS-21 incorporated in liposomes in 
complete medium, transferred into RPMI without phenol red, and 
analyzed by confocal vital imaging (Zeiss LSM710 confocal). For 
fluorescent tracer uptake, cells were seeded as above, incubated 
with 1 mg/ml lucifer yellow, 50 µg/ml 10 kDa dextran-Alexa647, 
and 50 µg/ml 40 kDa dextran-Texas Red for 16 h, washed, stimu-
lated with QS-21-containing liposomes for 4 h, and analyzed by 
confocal vital imaging. For NF-κB p65 nuclear translocation, 
p65 was detected following a classical immunofluorescence 
protocol described previously (20) using goat anti-p65 (Santa 
Cruz Biotechnology sc-372x—1/1,500 in PBS added with 0.1% 
Tween 20) and donkey anti-goat AlexaFluor594 (Invitrogen 
A11058—1/1,000) antibodies, and then visualized on a Zeiss 
LSM710 confocal microscope.
Flow cytometry
A total of 106 moDCs were activated overnight with the indicated 
stimulants. They were then washed in FACS buffer, resuspended 
in 50  µl, and FC receptors were blocked with human FcR 
Blocking Reagent (Miltenyi). Cells were then incubated with 
CD86-APC and HLA-DR-PE-Cy7 (eBioscience, 1/100). For 
innate cell recruitment to the draining lymph node, DLNs were 
treated by mechanical dissociation in 3  ml DMEM containing 
DNase I (100 mg/ml; Roche) and Liberase (0.26 U/ml; Roche) 
for 30 min. The cells were passed through a 100 mM cell strainer, 
resuspended in FACS buffer containing FC-blocking reagent 
(1/50; 2.4G2; BD Biosciences) and stained with: anti-Ly6C-APC, 
the PE-conjugated lineage identifiers (anti-SiglecF, anti-CD90.2, 
anti-CD19, and anti-NK1.1), anti-Ly6G-PerCPCy5, anti-Ly6C-
APC, anti-MHC class II (MHCII) (I-A/I-E)-FITC (eBioscience), 
anti-CD11b-V450, and anti-CD11c-PECy7. All Abs except 
the anti MHCII-FITC were obtained from BD Biosciences. To 
assess antigen (Ag)-specific T cell response, splenocytes from 
immunized mice were stimulated in vitro in a 96-well microplate 
with HBs peptide pools (GSK) at 1  µg/ml in the presence of 
anti-CD49d and anti-CD28 Abs, both 1 µg/ml (BD Biosciences). 
After 2 h, cytokine secretion was inhibited with 1 µg/ml brefeldin 
A (BD Biosciences), and cells were cultured overnight at 37°C. 
The cell were resuspended in FACS buffer containing Fc-blocking 
reagent (1/50; 2.4G2; BD Biosciences) and extracellular receptors 
were immunolabeled (Anti-CD4 pacific blue, clone RM 4-5 and 
anti-CD8-PerCP, clone 53-6.7) before permeabilization with 
Cytofix–Cytoperm (BD Biosciences). Cells were immunolabeled 
with anti-IFN-γ-APC (clone XMG1.2), anti-IL-2-FITC (clone 
JES6-5H4), and anti-TNF-PE (clone MP6-XT22). All antibodies 
were from BD Biosciences.
Microarray analysis
A total of 106 moDCs from four donors were stimulated with QS-21 
for 4 h in complete medium. Cells were washed with PBS, scraped, 
and lysed in 1 ml Tripure reagent (Roche Applied Science). RNA 
was extracted with chloroform and purified with the RNeasy 
Minikit (Qiagen) following manufacturer’s instructions, with 
DNase treatment of the column to remove possible genomic DNA 
contamination. RNA was concentrated by ethanol precipitation 
followed by resuspension in RNase-free water. RNA was quanti-
fied with a NanoDrop spectrophotometer. Biotinylated aRNA was 
generated from 100 ng total RNA using a Genechip 3′IVT express 
kit (Affymetrix, Santa Clara, CA, USA). Samples (10  µg bioti-
nylated and fragmented aRNA) were hybridized on a HG-U133A 
2.0 Expression chip (Affymetrix) for 16 h. Arrays were washed 
according to manufacturer’s recommendation and scanned using 
the Genechip scanner 3000 Affymetrix. Fold changes [QS-21 or 
3-O-desacyl-4′-monophosphoryl lipid A (MPL; GSK Vaccines) 
vs. medium] were calculated for each donor and a heatmap of 
top differentially expressed genes (FC > 5 or <0.5) was generated 
with MeV software. A volcano plot was generated with the aver-
age fold change and p-values for each gene using GraphPad Prism 
software. A scatter plot of fold changes vs. medium of QS-21 
(x axis) and MPL (y axis) was generated using the GraphPad 
Prism software.
Quantitative real-time Pcr
mRNA content of 2 × 105 moDCs was isolated with the MagNA 
Pure LC mRNA isolation kit (Roche) on the MagNA pure 
instrument (Roche Applied Science) following manufacturer’s 
indications. TNF, IL-6, IL-8, and IL-1β mRNAs were quantified 
by real-time PCR using TaqMan RNA Amplification Kit (Roche) 
or LightCycler Multiplex RNA Virus Master (Roche) on a Light 
Cycler 480 instrument (Roche Applied Science). Primers and 
probes were synthesized by Eurogentec (Actb: F: ggatgcagaagga 
gatcactg, R: cgatccacacggagtacttg, probe: ccctggcacccagcacaatg; 
Ctsb: F: tcccaccatcaaagagatca, R: atgcagatccggtcagagat, probe: 
tgtggctcctgctgggcctt; Syk: F: cagggaatatgtgaagcagaca, R: tccagct-
gaggcttctgact, probe tcaggctctggagcaggcca; IL1b: F: acagatgaagt-
gctccttcca, R: gtcggagattcgtagctggat, probe: ctctgccctctggatggcgg; 
IL6: F: gacagccactcacctcttca, R: agtgcctctttgctgctttc, probe: cctcga 
cggcatctcagccc; CXCL8/IL8: F: gccttcctgatttctgcagc, R: actgacatc 
taagttctttagcactcc, probe: tggcaaaactgcaccttcacacag, TNF: F: cccagg 
gacctctctctaatc, R: atgggctacaggcttgtcact, probe: tggcccaggcagtcaga 
tcatc). mRNA levels were normalized to β-actin mRNA expression.
sDs-Page and Western Blotting
A total of 106 moDCs were rinsed with PBS and lysed in 50 µl 
RIPA buffer (PBS with 1% Igepal CA-630, 0.5% Na deoxycholate 
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and 0.1% SDS) containing protease (cOmplete Mini Protease 
Inhibitor Cocktail Tablet, Roche) and phosphatase inhibitors 
(PhosSTOP, Roche). Lysed cells were incubated on ice for 
20 min, cleared by centrifugation at 12,000 g for 20 min at 4°C 
and stored at −80°C. Protein concentration was measured with 
the Micro BCA Protein Assay kit (Pierce) and 20 µg of protein 
was loaded onto a 12% Bis-Tris polyacrylamide gel. Gels were 
run in NuPAGE MOPS SDS Running Buffer (Invitrogen) at 
150 V for 1 h. Proteins were transferred onto a PVDF membrane 
(Amersham) for 1 h at 100 V, blocked in TBS-Tween contain-
ing 5% BSA, and blotted with rabbit anti-phospho-Zap-70 
(Tyr319)/Syk (Tyr352) (Cell Signaling #2701 1/1,000), rabbit 
anti-phospho-Syk (Tyr323) (Cell Signaling #2715 1/1,000), 
rabbit anti-Syk (Santa Cruz Biotechnology #sc-1077—1/500) 
and mouse anti-actin (Sigma-Aldrich clone AC-74—1/2,000) 
antibodies, followed by detection with donkey anti-rabbit/mouse 
IgG-HRP (GE Healthcare—1/5,000).
elisa
For cytokine measurements, 2  ×  105 moDCs were seeded in 
96-well plates and allowed to rest for 2 h. Cells were treated with 
the appropriate inhibitors and stimulated. The supernatants were 
collected after 24 h and ELISAs (hIL-6, hIL-8, hTNF) were car-
ried out following manufacturer’s instructions (R&D Systems). 
For Ag-specific antibody measurements, the HBs protein was 
used as the coating antigen and goat anti-mouse IgG (GAM—
SouthernBiotech or Jackson ImmunoResearch) was used as the 
coating antibody for the standard curve. Plates were blocked at 
room temperature for 1 h (PBS–1% BSA) and serial dilutions of 
serum samples and the IgG standard (SouthernBiotech) were 
added and incubated for 2 h at room temperature, followed by 
addition of biotin-conjugated anti-mouse IgG (Jackson Research 
or SouthernBiotech) and streptavidin-HRP. TMB was used as a 
substrate and plates were read at 450 nm on a microplate reader.
Virus Production and Transduction
pGIPZ vector-based short hairpin RNA (shRNA) targeting Syk 
(three constructs), cathepsin B (five constructs), and GAPDH as a 
control were purchased from Dharmacon. The following constructs 
exhibiting the highest knockdown capacity (verified by qPCR) 
for each target were selected (Syk: TCTATGATGTTCTTATCCT, 
cathepsin B: AACTTGACAGGGTGAAGCT). These vectors 
were transiently transfected into the human embryonic kidney 
HEK293T cells in combination with the packaging vector 
psPAX2 (Addgene plasmid 12259) and the VSV-G encoding plas-
mid pMD2.G as previously described (21). The supernatant was 
harvested 48 h after transfection and viruses were concentrated 
by ultracentrifugation and resuspension in Opti-MEM medium 
(Thermo Fisher). Viral titers were determined by transduction of 
293 T cells with serial dilutions of the concentrated virus stock 
followed by flow cytometric analysis of GFP expression. SIV 
virion-like particles (SIV-VLPs) were produced by cotransfect-
ing HEK293T cells with pMD2.G and pSIV3+ (22). moDCs 
were transduced as previously described (22, 23). Briefly, CD14+ 
monocytes were purified as described above, and seeded in 6-well 
plates in complete medium containing 800 U/ml GM-CSF, 200 U/
ml IL-4, 1 µg/ml polybrene, and 100 µl of supernatant containing 
SIV-VLPs. After 1 h, lentiviral particles were added at a MOI of 
1 and the plates were centrifuged for 1 h at 900 g at room tem-
perature. On day 3, 1 ml of medium containing 2,400 U GM-CSF 
and 600 U IL-4 was added to each well. The cells were recovered 
on day 6, and the transduction efficiency (GFP expression) was 
measured by flow cytometry (typically, between 80 and 90% of 
cells were transduced).
statistical analysis
Statistical analyses were performed using the GraphPad Prism 
software. Statistical significance for moDC data was determined 
either with a Wilcoxon matched-pairs signed-rank test or two-
way ANOVA followed by Tukey’s multiple comparisons test. 
Statistical significance for murine in vivo data was assessed using 
a Mann–Whitney test. p ≥  0.05: not significant; p <  0.05 and 
≥0.01: *; p < 0.01 and ≥0.001: **; p < 0.001 and ≥0.0001: ***; 
p < 0.0001: ****.
resUlTs
Qs-21 Promotes the activation and 
Maturation of human moDcs
QS-21 has been shown to activate the inflammasome in mouse 
macrophages and dendritic cells (14). In order to explore 
the signaling pathways involved in the immunostimulatory 
properties of saponins in human cells, monocyte-derived DCs 
(moDCs) were stimulated with increasing concentrations of 
QS-21 formulated into cholesterol-containing liposomes (here-
after referred to as “QS-21”), as in the clinical AS01 formulation. 
We observed dose-dependent induction of TNF, IL-6, and IL-8 
and selected 10 µg/ml for following experiments (Figure 1A). 
The activation of moDCs by QS-21 or MPL, a TLR4 ligand, was 
analyzed by flow cytometry for the surface expression of the 
class II major histocompatibility complex (MHCII) molecule, 
HLA-DR, and the costimulatory receptor, CD86. Both proteins 
were upregulated similarly by either QS-21- or MPL-stimulated 
moDCs, indicating that QS-21 promotes moDCs activation 
(Figure  1B). Furthermore, this effect was dependent on the 
QS-21 component as the liposomes alone did not induce 
upregulation of these markers (Figure 1C). Next, moDCs from 
four donors were stimulated with either QS-21 or MPL for 4 h 
and global gene expression was analyzed by microarray. PBS-
treated cells were used as the baseline to which both QS-21 and 
MPL treatments were compared. MPL was used as a control for 
its ability to uniquely activate TLR4 and to better discriminate 
QS-21-specific pathways.
In order to visualize changes in gene expression induced by 
QS-21, average microarray data were visualized on a “volcano 
plot” (Figure 1D). Overall, QS-21 induced significant upregula-
tion of 102 probe sets and downregulation of 43 (Table S1 in 
Supplementary Material). Comparison of transcript expression 
profiles between QS-21 and MPL with a scatter plot identified 
co-regulated genes and genes specifically regulated by either 
QS-21 or MPL at this time point (Figure 1E). Genes upregulated 
by both stimulants included cytokine or chemokine genes such 
as IL6, IL1A, IL1B, CXCL2, CXCL3, or CCL20, demonstrating 
FigUre 1 | Qs-21 directly activates human dendritic cells.  
(Continued)
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(a) moDCs were stimulated with increasing concentrations of QS-21, and IL-6, TNF, and IL-8 were quantified in the culture supernatant after 24 h. Statistical 
significance was determined by a Friedman test followed by Dunn’s multiple comparisons. The means and SEM from four donors are shown. (B) moDCs were 
stimulated with QS-21 (10 µg/ml) or MPL (1 µg/ml) for 24 h, and surface marker expression was evaluated by flow cytometry. Representative histograms of HLA-DR 
and CD86 MFI and bar graphs representing the mean and SEM of cumulative data from eight donors are shown. (c) moDCs were stimulated with QS-21 (10 µg/ml) 
or liposomes for 24 h and CD86 and HLA-DR expression were evaluated by flow cytometry (D–F) moDCs from four donors were stimulated with QS-21 or MPL for 
4 h and gene expression was analyzed by microarray. (D) Volcano plot of microarray data. Each point represents one gene plotted by log2 fold change (FC) vs. 
medium against −log10 of the p-value (average of four donors). The horizontal bar represents a p-value of 0.05. The light gray points represent genes with FC < 2 
and FC > 0.5 and black points represent FC > 2 or FC < 0.5. (e) Scatter plot analysis of microarray data. Log transformed FC vs. medium of QS-21 is plotted 
against FC vs. medium of MPL (average of four donors). The dotted lines represent FC = 1, the solid black line represents FCQS-21 = FCMPL and the red lines 
represent a FCQS-21/FCMPL ratio of +2 or −2. (F) Hierarchical clustering and heatmap representation of differentially expressed genes (FC vs. medium >2 or <0.5) for 
the four donors. The color-coded scale representing fold change vs. medium (blue = downregulated vs. medium, red = upregulated vs. medium) is indicated at the 
top of the chart. (g) InnateDB analysis of pathway over-representation of significantly upregulated genes (p-value < 0.05 and fold change > 2) for cells stimulated 
with QS-21 (left) or MPL (right) using the hypergeometric algorithm and Benjamini–Hochberg correction for p-values. (h) moDCs were stimulated with QS-21  
(10 µg/ml) or MPL (1 µg/ml) for the indicated durations, and IL-8, IL-1β, IL-6, and TNF transcript abundance was measured by qPCR. Data are from one donor 
representative of at least three independent experiments. (i) moDCs (n ≥ 5) were treated with Z-VAD-fmk (10 µM) and stimulated with QS-21 (10 µg/ml) or MPL 
(1 µg/ml), and IL-8, TNF, and IL-1β in the supernatant were measured by ELISA. (J) moDCs (n ≥ 5) were treated with recombinant IL-1 receptor antagonist 
(Anakinra—10 µg/ml) and stimulated with QS-21 (10 µg/ml) or IL-1β (10 ng/ml) and IL-8 was measured by ELISA. Statistical significance was determined by 
two-way ANOVA followed by Tukey’s multiple comparisons test.
FigUre 1 | continued
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a common inflammatory core response as previously reported 
for other adjuvants (24). Top upregulated probe sets identified 
as specific to QS-21 (FCQS-21 >  2 and FCMPL <  2) at this time 
point included RGS1, RGS2, NR4A2, DUSP1, and EGR1, which 
are primary response genes that are rapidly induced following 
cell activation with inflammatory stimuli (25–28). Clustering 
analysis of the top up- or downregulated genes for individual 
donors (FC vs. medium > 2 or FC vs. medium < 0.5) showed 
that individuals were clustered by stimulation (QS-21 vs. MPL) 
rather than by donor, indicating that the difference between 
MPL and QS-21 stimulation is greater than variations between 
different donors (Figure 1F). Pathway enrichment analysis with 
the InnateDB resource (29) identified pathways either shared by 
QS-21 and MPL, such as cytokine, Nod-like receptor (NLR), and 
G-protein-couple receptor signaling (Figure 1G), or specific to 
MPL such as TLR and IL-1 signaling, as expected (30). Pathways 
specific to QS-21 included AP-1 and ATF2 transcription fac-
tor networks, which mediate gene regulation in response to 
cytokines, stress signals, or infectious agents (31). Given that the 
QS-21-specific genes identified at this time point were known 
early response genes, we focused on the early expression kinetics 
of several upregulated cytokines shared by MPL and QS-21 by 
qPCR. Expression of these genes upon stimulation with QS-21 
or MPL showed different kinetics, suggesting that slower or more 
complex pathways were triggered by QS-21 (Figure 1H). Finally, 
since saponins including QS-21 can activate the inflammasome 
and promote the release of IL-1β, we examined whether caspase 
activation or IL-1β signaling were required for cytokine produc-
tion. Treatment of moDCs cells with the pan-caspase inhibitor 
Z-VAD-FMK had no effect on IL-8 or TNF production and, as 
expected, decreased IL-1β levels following QS-21 stimulation 
(Figure 1I). Furthermore, a recombinant IL-1 receptor antagonist 
had no effect on IL-8 production by cells stimulated with QS-21, 
but significantly decreased the response to IL-1β (Figure  1J). 
These results strongly suggest that cytokine production by 
QS-21-stimulated moDCs does not depend on inflammasome 
activation.
Membrane cholesterol is required for the 
endocytosis of Qs-21 and activation of 
immune cells
Next, we analyzed the mode of capture and subcellular 
localization of QS-21. In order to have a sufficient number of 
cells, phorbol 12-myristate 13-acetate (PMA)-differentiated 
monocytic THP-1 cells were used for both biochemical and 
fractionation experiments. Cells were first incubated at 4°C 
with the fluorescent analog BODIPY-QS-21 (formulated into 
cholesterol-containing liposomes), which arrests endocytosis 
and limits passive diffusion. At this temperature, the fluo-
rescence signal was exclusively detected at the cell surface. In 
contrast, after incubation at 37°C, QS-21 became detectable in 
distinct cytoplasmic, mostly perinuclear puncta (Figure  2A). 
To separately measure surface binding vs. intracellular uptake, 
we validated a surface stripping assay after incubation with 14C-
QS-21 (also formulated into cholesterol-containing liposomes) 
at 4°C. Surface digestion with trypsin or treatment with heparin 
sulfate virtually abolished cellular uptake, indicating that 
surface binding depended on plasma membrane proteins and 
electrostatic interactions (Figure 2B). To further exclude passive 
diffusion as mechanism of intracellular uptake, the ATP content 
was depleted by preincubation with azide/deoxyglucose and 
intracellular (trypsin-resistant) uptake of 14C-QS-21 was meas-
ured at 37°C. Similarly to incubation at 4°C, energy depletion 
abolished the intracellular uptake of QS-21 at 37°C, demonstrat-
ing an active process requiring cellular energy and resulting in 
its accumulation in endocytic structures (Figure 2C).
Given that saponins interact with cholesterol (8), we next 
examined the role of membrane cholesterol in the endocytosis 
of 14C-QS-21. Minimal depletion of membrane cholesterol 
(<10% loss) by the addition of 2.5  mM (low-dose) methyl-β-
cyclodextrin (MβCD), followed by extensive washing to eliminate 
residual MβCD, inhibited 14C-QS-21 uptake by ~50%, contrast-
ing with the absence of effect on the intracellular uptake of either 
125I-transferrin or 125I-cholera toxin B markers for clathrin- and 
FigUre 2 | Qs-21 is internalized by cholesterol-dependent endocytosis. (a) Imaging: THP-1 cells were incubated with 10 µg/ml BODIPY-QS-21 for 1 h at 
either 4°C or 37°C, and fluorescence was visualized by vital confocal microscopy. (B) Surface stripping: THP-1 cells (n = 3) were incubated at 4°C for 1 h with 
10 µg/ml 14C-QS-21, then extensively washed (Ctrl) or further stripped at 4°C by trypsin or heparin sulfate. (c) Endocytosis: Control or ATP-depleted THP-1 (n = 3) 
cells were incubated at 37°C for 4 h with 10 µg/ml 14C-QS-21, then stripped by trypsin as at (B). Parallel cells were incubated at 4°C. Statistical significance was 
determined by a one-way ANOVA followed by Tukey’s multiple comparisons test. (D) Cholesterol dependence: THP-1 cells (n = 2–3) were cholesterol depleted or 
not by treatment with 2.5 mM methyl-β-cyclodextrin (MβCD) for 4 h, extensively washed, then incubated with 14C-QS-21 for 1 h or 125I-transferrin or 125I-cholera 
toxin/B subunit (CTxB) for 15 min, surface-stripped by trypsin and counted. Statistical significance was determined by a two-way ANOVA followed by Sidak’s 
multiple comparisons test. (e,F) moDCs (n = 8) were treated with the indicated concentration of MβCD for 1 h, extensively washed and stimulated with QS-21 or 
MPL for 4 h. IL-6 (e) and TNF (F) mRNA abundance was measured by qPCR and normalized to β-actin expression. Statistical significance was determined by a 
Wilcoxon matched-pairs signed-rank test. The asterisks depict significant differences between 5–10 mM MβCD and 0 mM MβCD for QS-21 stimulated cells.
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caveolae/lipid-raft-mediated endocytosis (Figure 2D). Given that 
QS-21 endocytosis involves cholesterol, the effect of membrane 
cholesterol extraction on the response of moDCs to QS-21 was 
then investigated. Pretreatment of moDCs with MβCD inhibited 
their response to QS-21 but not to MPL, indicating that membrane 
cholesterol was a QS-21-specific requirement (Figures  2E,F). 
These results show that QS-21 was actively endocytosed in a 
cholesterol-dependent manner and that membrane cholesterol 
was crucial for the response to QS-21.
Qs-21 Mediates syk Kinase activation 
That is essential for response of moDcs
Membrane alterations, and more specifically membrane cho-
lesterol remodeling, can induce activation of the Syk kinase 
independently of receptor ligation (32). We therefore investi-
gated the role of this kinase in the response to QS-21. Dendritic 
cells were activated and Syk phosphorylation was measured 
by Western blotting. When cells were stimulated with QS-21, 
Syk phosphorylation increased on tyrosine 323 and 352, two 
known sites of Syk autophosphorylation (33), to a comparable 
extent as in response to MPL or zymosan, a known inducer of 
Syk phosphorylation (Figures 3A,B). Blockade of Syk activity 
by BAY 61-3606 (34) inhibited response to QS-21 in moDCs, 
as seen by the reduction of TNF, IL-6, and IL-8 secretion 
(Figures  3C–E). Since pharmacological compounds can lack 
specificity, Syk expression was also inhibited by shRNA inter-
ference. CD14+ monocytes were transduced during their dif-
ferentiation into moDCs with lentiviral particles encoding Syk 
or GAPDH shRNAs, as previously described (22). Syk mRNA 
knockdown, measured by quantitative PCR, was greater than 
50% when compared to cells expressing an shRNA specific to 
GAPDH (Figure 3F). Syk knockdown strongly decreased both 
IL-6 and TNF mRNA expression induced by QS-21, confirming 
the results obtained with the inhibitor (Figures 3G,H). Finally, 
the effect of Syk inhibition on NF-κB activation was investigated 
by observing p65 nuclear translocation. Syk inhibition by BAY 
61-3606 strongly decreased QS-21-induced p65 translocation 
to the nucleus, indicating that Syk activity is required for both 
NF-κB activation and cytokine production (Figure 3I).
FigUre 3 | syk activation and signaling is indispensable for response to Qs-21 in moDcs.
(Continued)
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lysosomal Destabilization Mediates the 
response of human Dcs to Qs-21
The punctate pattern of cells incubated with BODIPY-QS-21 
(Figure 2A) suggested that QS-21 may be confined to a specific 
subcellular compartment or structure. We therefore established 
the subcellular distribution of 14C-QS-21 by density gradient 
fractionation in THP-1 cells after 4  h of pulse and overnight 
chase. Equilibration of postnuclear particles in Percoll gradients 
fully resolved the plasma membrane (Western blotting for Na+/
K+-ATPase, buoyant fractions) from lysosomes (N-acetyl-β-
hexosaminidase activity, dense fractions) (Figure  4A). In the 
absence of surface stripping by trypsin, the density distribution of 
QS-21 was bimodal between these two positions in the gradient, 
indicating two pools at the plasma membrane and lysosomes, 
respectively. When cell surface proteins and associated material 
were stripped by trypsin digestion, the intracellular pool of QS-21 
perfectly co-distributed with dense lysosomes. Colocalization of 
BODIPY-QS-21 with LysoTracker Red confirmed that internal-
ized QS-21 was concentrated in lysosomes (Figure 4B).
Since saponins can interact with cell membranes and induce 
pore formation (8), we next examined the effect of QS-21 on 
lysosomal integrity. AO is a lysosomotropic dye that emits red 
fluorescence when concentrated under acidic conditions. moDCs 
preincubated with AO showed a rapid, yet partial decrease in 
red fluorescence upon stimulation with QS-21, indicating loss 
of lysosomal acidification or membrane integrity (Figure  4C). 
To investigate whether this second possibility could be due to 
saponin-mediated pore formation, moDCs were incubated with 
FigUre 3 | continued  
(a,B) Immunoblot analysis of cytoplasmic extracts of moDCs stimulated with QS-21, MPL, or Zymosan (Zym) for the indicated durations. Blots were probed 
sequentially with pY323-SYK (a) or pY352-SYK (B), followed by total Syk. (c–e) moDCs were treated with Bay 61-3606 (10 µM) for 1 h and stimulated with QS-21 
(10 µg/ml) for 24 h. IL-6 (c), TNF (D), and IL-8 (e) were quantified in the supernatant by ELISA. Statistical significance was determined by a Wilcoxon matched-pairs 
signed-rank test. (F–h) moDCs were transduced with lentiviruses coding for shRNAs targeting GAPDH or Syk, and Syk (F), IL-6 (g), and TNF (h) mRNA expression 
were measured by qPCR and normalized against β-actin expression. Statistical significance was determined by a Wilcoxon matched-pairs signed-rank test. 
(i) moDCs were seeded on coverslips, treated with Bay 61-3606 (10 µM) for 1 h and stimulated with 10 µg/ml QS-21 for 2 h. NF-κB p65 was visualized by 
immunofluorescence and nuclear p65 was quantified using ImageJ software. Data are representative of three experiments. Statistical significance was determined 
with a non-parametric Mann–Whitney t-test. 
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fluorescent endocytic markers of different molecular weights. 
In untreated cells, Lucifer Yellow, a very small yet membrane-
impermeant lysosomal endocytic tracer (LY; 522 Da), as well as 
two dextrans of different sizes (10  kDa Alexa647-Dextran and 
40 kDa Texas Red-Dextran) co-localized in lysosomes after 16 h. 
After stimulation with QS-21, tracers were detected in the cytosol 
(80% of cells for the small LY and 60% for the two dextrans) 
(Figure  4D). Furthermore, in 40% of cells, LY fluorescence 
showed only a diffuse signal with loss of puncta, while both 
dextrans were still visible in lysosomes. QS-21 therefore partially 
permeabilized lysosomal membranes with a selectivity in pore 
size, resulting in widespread cytosolic diffusion of the small 
tracer but only partial diffusion of the two dextran polymers. 
To determine whether low lysosomal pH was a crucial factor for 
the response to QS-21, lysosomal acidification was blocked by 
inhibition of the vacuolar ATPase by bafilomycin A1 (BafA1), 
or by incubation with the weak base ammonium chloride 
(NH4Cl). Incubation of moDCs with either agents lessened both 
QS-21-induced IL-6 and TNF mRNA transcription (Figure 5A) 
and cytokine release (Figure 5B). No such effect was observed 
upon stimulation with MPL, excluding a defect in IL-6 secre-
tion. BafA1 treatment also inhibited Syk Y352 phosphorylation 
induced by QS-21 but not by zymosan, strongly suggesting that 
QS-21 induced Syk phosphorylation takes place downstream of 
lysosomal destabilization (Figure  5C). Finally, pretreatment of 
cells with BafA1 had no effect on QS-21-induced relocation of 
either LY or dextrans from the lysosomes to the cytosol, indicat-
ing that lysosome pore formation occurred even if acidification 
was inhibited (Figure 5D). These results suggest that acidic pH in 
lysosomes and lysosomal membrane permeabilization by QS-21 
are necessary for the activation of moDCs.
lysosomal cathepsin B Mediates the 
response to Qs-21 in human Dendritic 
cells
Some lysosomal cathepsins are reported to activate NF-κB-
mediated transcriptional events when released into the cytosol 
(35, 36). To screen for involvement of member(s) of this protease 
family in QS-21-mediated activation of moDCs, cells were 
FigUre 4 | Qs-21 accumulates in lysosomes and promotes their destabilization. (a) Differentiated THP-1 cells were pulsed with 14C-QS-21 for 4 h followed 
by an overnight chase, and postnuclear particles were resolved by density gradients fractionation. Na+/K+-ATPase identifies the plasma membrane and N-acetyl-β-
hexosaminidase activity identifies lysosomes. The abscissa axis represents the different fractions. The ordinate reflects enrichment (C/Ci > 1) or depletion (C/Ci < 1) 
vs. initial abundance (Ci = 1), indicated by dotted lines. (B) Differentiated THP-1 cells were co-incubated with BODIPY-QS-21 and Lysotracker Red then analyzed by 
vital confocal microscopy. (c) moDCs were incubated with 1 µg/ml acridine orange (AO), washed, and stimulated for 2 h with QS-21 (10 µg/ml). AO fluorescence 
was quantified by flow cytometry and a 610 nm filter. Cells with decreased AO fluorescence are indicated with the double arrow. One representative donor of 3 is 
shown. (D) moDCs were incubated with Lucifer Yellow, 10 kDa dextran-Alexa633 and 40 kDa dextran-Texas Red for 16 h then stimulated for QS-21 for 4 h. The 
localization of fluorescent markers was observed by confocal microscopy. The proportion of cells with punctate (lysosomal), diffuse (cytoplasmic) or both 
(punctate + diffuse) signal for the different fluorescent markers was determined with ImageJ. The data are representative of four donors.
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FigUre 5 | Qs-21-mediated dendritic cell activation and syk phosphorylation depend on lysosomal maturation. (a,B) moDCs were treated with 
bafilomycin A1 (BafA1—250 nM) or NH4Cl (10 mM) for 1 h and stimulated with QS-21 (10 µg/ml) or MPL (1 µg/ml) for 4 h (a) or 24 h (B). TNF and IL-6 mRNA (A) 
and protein (B) were quantified by qPCR (n = 8) and ELISA (n = 11), respectively. Statistical significance was determined by two-way ANOVA followed by Tukey’s 
multiple comparisons test. (c) moDCs were treated with BafA1 for 1 h and stimulated with QS-21 (10 µg/ml) or zymosan as a positive control (Zym—50 µg/ml) for 
2 h. Phospho-Syk (Y352), Syk, and β-actin were detected by sequential western blotting. One representative donor of 2 is shown. (D) moDCs were incubated with 
Lucifer Yellow, 10 kDa dextran-Alexa633, and 40 kDa dextran-Texas Red for 16 h then pretreated with BafA1 or DMSO (vehicle) and stimulated with QS-21 for 4 h. 
The localization of fluorescent markers was observed by confocal microscopy. The proportion of cells with punctate (lysosomal), diffuse (cytoplasmic), or both 
(punctate + diffuse) signals for the different fluorescent markers was determined with ImageJ. The data are representative of two donors.
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pretreated with the following inhibitors before challenge with 
QS-21: CA-074 Me and Z-FA-FMK (cathepsin B); Z-FF-FMK 
(cathepsin L), or pepstatin A (cathepsin D, cathepsin E). Only 
the two first inhibitors significantly decreased QS-21-mediated 
TNF production, pointing to a specific involvement of cathepsin 
B in this response (Figure  6A). Cathepsin B inhibition with 
either CA-074 Me or Z-FA-FMK also inhibited QS-21-induced 
TNF and IL-6 mRNA expression with no effect on MPL-induced 
gene expression, indicating that the effect was transcriptional and 
specific to QS-21 (Figure 6B). Finally, shRNA-mediated knock-
down of cathepsin B strongly decreased the expression of both 
TNF and IL-6 mRNAs, confirming that cathepsin B expression 
is essential for QS-21-mediated cytokine production in human 
DCs (Figures 6C,D).
FigUre 6 | cathepsin B activity is required for an optimal response to Qs-21. (a) moDCs were incubated with CA-074 Me (cathepsin B inhibitor), Z-FA-FMK 
(cathepsin B inhibitor), Z-FF-FMK (cathepsin B/L inhibitor), or pepstatin A (cathepsin D, cathepsin E, and pepsin inhibitor) for 1 h and stimulated with QS-21 for 24 h. 
TNF release into the supernatant was measured by ELISA. Statistical significance was determined with a Friedman test followed by Dunn’s multiple comparison test. 
(B) moDCs were pretreated with CA-074 Me or Z-FA-FMK for 1 h and stimulated with QS-21 or MPL for 6 h. IL-6 and TNF mRNA levels were quantified by qPCR 
and normalized to β-actin mRNA levels. Statistical significance was determined by two-way ANOVA followed by Tukey’s multiple comparisons test. (c,D) moDCs 
were transduced with lentiviruses coding for shRNAs targeting GAPDH (shGAPDH) or cathepsin B (shCtsb), and cathepsin B (c), IL-6 and TNF (D) mRNA 
expression were measured by qPCR and normalized against β-actin expression. Statistical significance was determined by a Wilcoxon matched-pairs  
signed-rank test.
12
Welsby et al. QS-21 Activates Human Dendritic Cells
Frontiers in Immunology | www.frontiersin.org January 2017 | Volume 7 | Article 663
cathepsin B is essential for Optimal 
antigen-specific Qs-21-Mediated T cell 
responses In Vivo
To assess the role of cathepsin B in the adjuvant effect of QS-21 
in vivo, we first evaluated the recruitment of inflammatory cells 
to the lymph node draining the site of QS-21 injection. In both 
WT and cathepsin B KO mice, QS-21 induced the recruitment 
of monocytes and neutrophils, and to a lesser extent dendritic 
cells 24 h post-immunization (Figure 7A), suggesting that other 
pathways may contribute to these early events in vivo. Next, to 
evaluate a possible role of cathepsin B in adaptive responses, WT 
or cathepsin B KO mice were immunized intramuscularly with 
either HBsAg or HBsAg adjuvanted with QS-21. HBsAg is the 
antigen used in the Engerix-BTM vaccine. Mice were immunized 
following a prime (at day 0)-boost (at day 14) regimen and 
the Ag-specific adaptive responses were measured at day 21. 
The frequency of cytokine (IL-2, TNF, and IFN-γ)-producing 
Ag-specific T cells, measured by flow cytometry following ex vivo 
restimulation with antigenic peptides, was significantly lower in 
cathepsin B-deficient mice than in their wild-type counterparts 
for both HBsAg-specific CD4 and CD8 T cells (Figure 7B). A 
strong decrease in IFN-γ and IL-2 secretion was also observed in 
the supernatants of cathepsin B-deficient splenocytes in the same 
experimental setting (Figure 7C). However, despite these marked 
defects in both CD4 and CD8 Ag-specific T cells responses, anti-
body titers were not significantly reduced (Figure 7D).
DiscUssiOn
QuilA saponins, and QS-21 in particular, are well-known adju-
vants but, excluding NLRP3 inflammasome activation, little is 
known about the molecular and cellular mechanisms leading 
to their adjuvant effect. Here, we demonstrate that cholesterol-
dependent endocytosis is required to induce human moDC 
activation and that QS-21 accumulates in lysosomes and causes 
lysosomal membrane permeabilization. Cell activation depends 
on the activity of the Syk kinase and of cathepsin B (Figure 7E). 
Finally, we established that cathepsin B participates in the adjuvant 
properties of QS-21 on both CD4 and CD8 antigen-specific-T cell 
responses in vivo.
QS-21 is a saponin with specific affinity for cell mem-
brane cholesterol that can induce pore formation therein (8). 
Co-formulation with cholesterol is required to avoid toxicity 
when used as injectable (10). In this study, we used QS-21 formu-
lated in liposomes containing cholesterol and thereby devoid of 
any measurable lytic activity. Membrane cholesterol in the target 
cells was required for both cell entry and activation, suggesting 
that either QS-21 is transferred from liposomal cholesterol to the 
FigUre 7 | Qs-21 elicited antigen-specific cD4 and cD8 T cell responses are dependent on cathepsin B. (a) Monocyte (CD11b+ Ly6C+ Ly6G−), 
neutrophil (CD11b+ Ly6Cint Ly6G+), and dendritic cell (CD11chi MHCIIhi) recruitment to the draining lymph node 24 h post intramuscular immunization with PBS or 
QS-21 assessed by flow cytometry. (B) WT and cathepsin B (Ctsb)-invalidated mice were immunized at day 0 and day 14 with hepatitis B surface (HBs) antigens or 
with HBs antigens adjuvanted with QS-21. At day 21, median cytokine production of HBsAg-specific splenic CD4 and CD8 T cells were evaluated by intracellular 
staining following ex vivo restimulation with antigenic peptides (Ag: n = 6, QS-21: n = 20). (c) IFN-γ and IL-2 production by HBs-specific spleen cells were 
measured by ELISA following restimulation with HBs peptides (Ag: n = 3, QS-21: n = 10). (D) Anti-HBs IgG1 and IgG2c titers in the serum at day 21 were measured 
by ELISA (Ag: n = 6, QS-21: n = 26). Each dot represents one mouse, and the horizontal bar represents the geometric mean. Statistical significance was 
determined by a non-parametric Mann–Whitney t-test. The data represent the pooled results of two independent experiments. (e) Proposed model: QS-21 is 
endocytosis via a cholesterol-dependent mechanism. It then traffics to lysosomes and induces their destabilization. This can induce inflammasome activation and 
Syk- and cathepsin B-dependent cell activation and cytokine production in moDCs. Lysosomal destabilization could also affect antigen processing and antigen 
translocation to the cytosol.
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cell membrane-associated cholesterol or that the whole liposome 
containing QS-21 is endocytosed via a cholesterol-dependent 
mechanism. Partial depletion of membrane cholesterol did not 
impact the endocytosis of either transferrin (TfR) or cholera toxin 
B (CTxB), arguing against clathrin-dependent and caveolin/lipid 
raft-dependent mechanisms for endocytosis of liposomal QS-21 
(37). Cell entry could instead be mediated through cholesterol-
dependent macropinocytosis as shown for several viruses (38–
42). Macropinocytosis of viruses can be receptor mediated (42), 
which could explain the surface protein dependence we observed 
for QS-21. Irrespective of the mechanism of entry, QS-21 was 
eventually transferred to and concentrated in dense lysosomes 
where it promoted lysosomal destabilization and the potential 
release of lysosomal content. Because particles of up to 40 kDa 
could leak out of lysosomes upon incubation with QS-21, it is 
likely that pores were formed in the lysosomal membrane. Several 
mechanisms could explain why QS-21 could form pores in 
lysosomal membranes but not in plasma membranes. On the one 
hand, due to the lysosomal accumulation and lengthy retention 
of QS-21, cholesterol may be preferentially extracted by QS-21 in 
these organelles. Reduced lysosomal membrane cholesterol has 
been linked to increased permeability to positive ions leading 
to osmotic imbalance and lysosomal destabilization (43–45). 
Lysosome destabilization by listeriolysin and lysosomotropic 
detergents is dependent on acid-driven conformational changes 
occurring in this organelle (46, 47). This does not seem to be the 
mechanism for QS-21, as inhibition of lysosome acidification did 
not affect QS-21-mediated pore formation. Interestingly, inhibi-
tion of lysosome acidification also inhibits the response to QS-21 
in human PBMCs. Indeed, treatment with chloroquine inhibited 
QS-21-induced production of IL-6 by PBMCs, although no effect 
of chloroquine administration was observed on T cell or antibody 
responses in healthy adults immunized with AS01-adjuvanted 
antigens (48).
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QS-21-mediated pore formation resulted in the translocation 
of macromolecules from lysosomes to the cytosol and induced 
activation marker upregulation and cytokine transcription. This 
complex activation pathway is most likely the reason for the differ-
ent expression kinetics observed by PCR for cytokines induced by 
QS-21 when compared to MPL. Furthermore, the genes upregu-
lated specifically by QS-21 identified in the microarray included 
EGR1, RGS1, NR4A2, and DUSP1 that are known TLR4-induced 
primary response genes. These genes are expressed as rapidly as 
15 min following TLR4 stimulation and their expression returns 
to baseline after 2–3 h (25–28). It is therefore likely that after 4 h, 
the time point chosen for the microarray analysis, the expression 
of these genes, had returned to baseline after stimulation with 
MPL but not yet with QS-21.
Other groups have reported that lysosomal permeabilization 
by compounds including Alum and QuilA activates the inflam-
masome, although pro-IL-1β expression required priming 
with a TLR-ligand (15, 49, 50). In contrast, here we show that 
QS-21 directly promoted the expression of pro-IL-1β and other 
cytokines. This discrepancy between our study and previous 
work may be due to the cell type studied or to the formulation. 
Indeed, a recent study has shown that stimulation with unfor-
mulated (i.e., not formulated with liposomes) QS-21 does not 
lead to the direct activation of murine bone marrow-derived 
dendritic cells or macrophages (14). It is possible that formula-
tion of QS-21 with cholesterol-containing liposomes allows for 
better lysosomal targeting and activation of alternative signal-
ing pathways. Cell type specificity has also been observed for 
saponin-dependent translocation of endocytosed antigens, as it 
occurs in human moDCs but not in human monocytes or mac-
rophages (6). Human dendritic cells derived from monocytes 
in  vitro have an increased capacity for lysosomal proteolysis 
when compared to other human or mouse dendritic cells and 
express high levels of lysosomal cathepsins B, D, L, and S (51). 
This distinctive characteristic may explain why saponins could 
promote both antigen translocation in and direct activation of 
human moDCs.
We have indeed shown that cathepsin B expression and activ-
ity are critical for the response of moDCs to QS-21. Furthermore, 
lysosomal cysteine proteases, such as cathepsins B and L, are 
involved in inflammasome activation downstream of lysosomal 
destabilization following stimulation with saponins (14, 15). 
The exact mechanism by which cathepsin B could promote the 
transcription of pro-inflammatory cytokines remains elusive, 
although a role for cathepsins in NF-κB activation has already 
been described. The synthetic double-stranded RNA, poly IC, 
can induce lysosomal destabilization and cathepsin D release into 
the cytosol, where it mediates the cleavage of caspase-8, which is 
important for increased NF-κB activity (36). In our experiments 
however, cathepsin B did not seem to cleave caspase-8, as no 
cleavage fragments were detectable in cells stimulated with QS-21 
(data not shown). Cathepsin B has nevertheless multiple other 
potential lysosomal and cytoplasmic targets.
In vivo, cathepsin B was not involved in Ag-specific antibody 
responses promoted by QS-21 or innate cell recruitment to the 
draining lymph node, yet cathepsin B-deficient mice showed 
decreased HBsAg-specific CD4 and CD8 T cell responses. This 
discrepancy could be due to a general defect in antigen presen-
tation. Indeed, cathepsin B activity has been linked to antigen 
processing, which could affect antigen presentation on both 
class I and class II major histocompatibility complexes (52–56). 
Interestingly, ISCOMATRIX was shown to induce antigen 
translocation from lysosomes to the cytosol, thereby facilitating 
proteasome-independent cross-priming (6). We have also shown 
that QS-21 promotes pore formation in lysosomal membranes 
allowing the release of macromolecules of up to 40 kDa into the 
cytosol. Cathepsin B could partially degrade protein antigens in 
the lysosome and the fragments could be released into the cytosol 
by QS-21 for cross-presentation. It is, however, unlikely that this 
mechanism contributes to lessened QS-21-elicited Ag-specific 
CD8 T cell responses observed in cathepsin B-deficient mice, 
since QS-21 and antigens display different localizations and 
pharmacokinetic properties after immunization (16).
We have also identified Syk as a key signaling molecule for 
the response of moDCs to QS-21. Indeed, Syk was phosphoryl-
ated following QS-21 stimulation and Syk knockdown or phar-
macological inhibition blocked NF-κB activation and cytokine 
production. Syk is a tyrosine kinase generally associated with 
ITAM-motif containing receptors (57), and can also play a role 
in lysosomal function in B cells. For example, B cell receptor 
cross-linking causes Syk-dependent changes in lysosomal pH, 
which lead to apoptosis (58). However, in our system, Syk was 
found to act downstream of lysosomal function, as bafilomycin 
A1 blocked QS-21-mediated Syk phosphorylation. Syk may 
therefore play a role of lysosomal integrity sensor and auto- 
phosphorylate following lysosomal membrane damage, a pos-
sibility that has already been suggested (59). Since Syk kinase 
can be activated by plasma membrane lipid alterations, it is 
possible that a similar mechanism could occur at the lysosomal 
membrane (32, 60). However, neither Syk relocation to nor 
phosphorylation at the lysosomal membrane could be detected 
by confocal microscopy in our system (data not shown). 
Nevertheless, Syk could promote cathepsin B proteolytic 
activity as has been shown in other models (61). In summary, 
we describe a novel lysosome-dependent pathway (Figure 7G) 
that contributes to the immunostimulatory properties of a 
clinically approved saponin-based vaccine adjuvant. This 
knowledge may help the rational development of adjuvants 
which could be instrumental to the success of future vaccina-
tion strategies.
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